Effect of modifications of the Alkylpiperazine moiety of trazodone on 5HT2A and α1 receptor binding affinity

被引:30
|
作者
Giannangeli, M
Cazzolla, N
Luparini, MR
Magnani, M
Mabilia, M
Picconi, G
Tomaselli, M
Baiocchi, L
机构
[1] Angelini Ric SpA, Dept Med Chem, I-00040 S Palomba Pomezia, Rm, Italy
[2] Angelini Ric SpA, Dept Neuropharmacol, I-00040 S Palomba Pomezia, Rm, Italy
[3] Soluz Informat SAS, I-36100 Vicenza, Italy
关键词
D O I
10.1021/jm970700n
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of triazolopyridine derivatives (compounds 2a-I) were synthesized in order to-explore the effect of modifications of the alkylpiperazine moiety of trazodone (fragment A) on binding affinity for 5HT(2A) and alpha(1) receptors. All of the synthesized compounds show a decrease of affinity for both 5HT(2A) and alpha(1) receptors, as compared to trazodone, with the exception of compounds 2b,c which bear a methyl group in an alpha position to the aliphatic nitrogen atom N-1. These compounds showed a decrease of affinity only for the alpha(1) receptor. The stereochemical influence of the piperazine moiety of compound 2c was also evaluated. Enantiomer (S)-2c showed the most significant differences between 5HT(2A) and alpha(1) receptor affinity (IC50 values) and among the corresponding functional properties (pA(2) values). Since (S)-2c cannot generate the metabolite 4-(3-chlorophenyl)piperazine this product was selected for further pharmacological studies.
引用
收藏
页码:336 / 345
页数:10
相关论文
共 50 条
  • [1] 5HT2A receptor binding is increased in borderline personality disorder
    Soloff, Paul H.
    Price, Julie C.
    Meltzer, Carolyn C.
    Fabio, Anthony
    Frank, Guido K.
    Kaye, Walter H.
    BIOLOGICAL PSYCHIATRY, 2007, 62 (06) : 580 - 587
  • [2] 5HT2A receptor binding of ACP-104 in schizophrenia
    Wong, D. F.
    Cascella, N.
    Zhou, Y.
    Brasic, J.
    Ye, W.
    Alexander, M.
    Tamminga, C.
    van Kammen, D. P.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 398 - 398
  • [3] 5HT2a receptor gene and response to clozapine
    Pedrini, S
    Verga, M
    Mencacci, C
    Macciardi, F
    SCHIZOPHRENIA RESEARCH, 1999, 36 (1-3) : 94 - 94
  • [4] Imprinting of the 5HT2A receptor in schizophrenia.
    Sodhi, MS
    Ansari, D
    Bush, ES
    Harrison, PJ
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 332 - 332
  • [5] DIRECT DETERMINATION OF KINETIC AND EQUILIBRIUM BINDING OF FLIBANSERIN TO 5HT1A AND 5HT2A RECEPTORS
    Kim, N.
    JOURNAL OF SEXUAL MEDICINE, 2019, 16 (06): : S12 - S12
  • [6] Antagonists for 5HT1A and 5HT2A receptors.
    Schmall, B
    Lang, L
    Jagoda, E
    Channing, M
    Sassaman, M
    Eckelman, WC
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) : 929 - 929
  • [7] Increased 5HT2A receptor binding in frontal cortex of schizophrenic subjects : Effect of aging and antipsychotic drug treatment
    Garcia-Bea, A.
    Muguruza, C.
    Miranda-Azpiazu, P.
    Moreno, J. L.
    Umali, A.
    Callado, L. F.
    Gabilondo, A. M.
    Gonzalez-Maeso, J.
    Meana, J. J.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 115 - 115
  • [8] Serotonin 5HT2a receptor variation and episodic memory
    不详
    NEUROSCIENTIST, 2004, 10 (05): : 401 - 401
  • [9] Investigation of Novel Inhibitor for the Serotonin 5HT2A Receptor
    Alshbool, Fatima Z.
    Karim, Zubair A.
    Khasawneh, Fadi T.
    FASEB JOURNAL, 2019, 33
  • [10] 5HT1A and 5HT2A receptor genes in treatment response phenotypes in major depressive disorder
    Noro, Magali
    Antonijevic, Irina
    Forray, Carlos
    Kasper, Siegfried
    Kocabas, Neslihan Aygun
    Lecrubier, Yves
    Linotte, Sylvie
    Mendlewicz, Julien
    Montgomery, Stuart
    Snyder, Lenore
    Souery, Daniel
    Verbanck, Paul
    Zohar, Joseph
    Massat, Isabelle
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2010, 25 (04) : 228 - 231